AAIC 2025 Abstract·23 DecEfficacy and Safety of Oral Valiltramiprosate in APOE4/4 Homozygotes with Early AD: Topline Results from the APOLLOE4 Phase 3 TrialTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecSafety and ARIA Results of the Oral Anti‐Amyloid Agent Valiltramiprosate from the Phase 3 APOLLOE4 Trial in APOE4/4 Homozygotes with Early ADTrial in peopleInterventionsPaper